Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)
23.75
+0.27 (1.15%)
May 30, 2025, 3:00 PM CST
SHA:600285 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | May '25 May 29, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Market Capitalization | 13,375 | 12,480 | 9,649 | 7,358 | 8,920 | 4,809 | Upgrade
|
Market Cap Growth | -1.86% | 29.34% | 31.14% | -17.51% | 85.47% | -14.44% | Upgrade
|
Enterprise Value | 12,634 | 11,552 | 8,482 | 6,324 | 8,108 | 4,064 | Upgrade
|
Last Close Price | 23.75 | 22.16 | 16.56 | 12.16 | 14.15 | 7.29 | Upgrade
|
PE Ratio | 17.89 | 17.27 | 16.98 | 15.81 | 24.67 | 14.78 | Upgrade
|
Forward PE | 16.05 | 16.50 | 16.45 | 14.45 | 15.43 | 15.43 | Upgrade
|
PS Ratio | 3.70 | 3.57 | 2.91 | 2.45 | 3.31 | 2.06 | Upgrade
|
PB Ratio | 4.00 | 4.05 | 3.45 | 2.88 | 3.90 | 2.07 | Upgrade
|
P/TBV Ratio | 5.32 | 4.35 | 3.73 | 3.14 | 4.37 | 2.32 | Upgrade
|
P/FCF Ratio | 16.15 | 16.40 | 12.18 | 9.11 | 11.60 | 12.70 | Upgrade
|
P/OCF Ratio | 14.10 | 14.25 | 11.86 | 8.81 | 10.55 | 10.68 | Upgrade
|
EV/Sales Ratio | 3.50 | 3.30 | 2.56 | 2.11 | 3.01 | 1.74 | Upgrade
|
EV/EBITDA Ratio | 15.21 | 14.52 | 12.76 | 13.65 | 18.11 | 10.57 | Upgrade
|
EV/EBIT Ratio | 16.67 | 15.96 | 14.40 | 16.25 | 21.54 | 12.85 | Upgrade
|
EV/FCF Ratio | 15.26 | 15.19 | 10.71 | 7.83 | 10.55 | 10.73 | Upgrade
|
Debt / Equity Ratio | 0.03 | 0.03 | 0.07 | 0.06 | 0.12 | 0.07 | Upgrade
|
Debt / EBITDA Ratio | 0.11 | 0.12 | 0.31 | 0.34 | 0.63 | 0.43 | Upgrade
|
Debt / FCF Ratio | 0.11 | 0.13 | 0.26 | 0.20 | 0.37 | 0.44 | Upgrade
|
Asset Turnover | 0.70 | 0.72 | 0.73 | 0.74 | 0.74 | 0.69 | Upgrade
|
Inventory Turnover | 2.05 | 1.88 | 1.86 | 1.83 | 1.86 | 1.77 | Upgrade
|
Quick Ratio | 0.80 | 1.07 | 1.11 | 1.16 | 1.16 | 1.45 | Upgrade
|
Current Ratio | 1.01 | 1.31 | 1.37 | 1.47 | 1.48 | 1.80 | Upgrade
|
Return on Equity (ROE) | 23.83% | 24.58% | 21.21% | 19.21% | 15.73% | 14.28% | Upgrade
|
Return on Assets (ROA) | 9.12% | 9.24% | 8.08% | 5.98% | 6.49% | 5.83% | Upgrade
|
Return on Capital (ROIC) | 14.78% | 14.63% | 12.86% | 9.20% | 9.31% | 7.92% | Upgrade
|
Return on Capital Employed (ROCE) | 22.10% | 23.00% | 20.50% | 14.80% | 16.00% | 13.20% | Upgrade
|
Earnings Yield | 5.60% | 5.79% | 5.89% | 6.32% | 4.05% | 6.77% | Upgrade
|
FCF Yield | 6.19% | 6.10% | 8.21% | 10.98% | 8.62% | 7.87% | Upgrade
|
Dividend Yield | 3.79% | 4.06% | 4.83% | 4.94% | 3.53% | 5.49% | Upgrade
|
Payout Ratio | 60.31% | 62.47% | 60.60% | 62.08% | 61.91% | 55.03% | Upgrade
|
Buyback Yield / Dilution | 0.32% | 0.42% | 0.30% | -0.26% | 0.24% | 1.22% | Upgrade
|
Total Shareholder Return | 4.11% | 4.48% | 5.13% | 4.68% | 3.77% | 6.71% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.